1. Home
  2. OXLCO vs CMMB Comparison

OXLCO vs CMMB Comparison

Compare OXLCO & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OXLCO
  • CMMB
  • Stock Information
  • Founded
  • OXLCO N/A
  • CMMB 2004
  • Country
  • OXLCO United States
  • CMMB Israel
  • Employees
  • OXLCO N/A
  • CMMB N/A
  • Industry
  • OXLCO Investment Managers
  • CMMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • OXLCO Finance
  • CMMB Health Care
  • Exchange
  • OXLCO Nasdaq
  • CMMB Nasdaq
  • Market Cap
  • OXLCO N/A
  • CMMB 37.3M
  • IPO Year
  • OXLCO N/A
  • CMMB N/A
  • Fundamental
  • Price
  • OXLCO $23.05
  • CMMB $1.97
  • Analyst Decision
  • OXLCO
  • CMMB Strong Buy
  • Analyst Count
  • OXLCO 0
  • CMMB 2
  • Target Price
  • OXLCO N/A
  • CMMB $7.50
  • AVG Volume (30 Days)
  • OXLCO N/A
  • CMMB 82.4K
  • Earning Date
  • OXLCO N/A
  • CMMB 03-06-2025
  • Dividend Yield
  • OXLCO N/A
  • CMMB N/A
  • EPS Growth
  • OXLCO N/A
  • CMMB N/A
  • EPS
  • OXLCO N/A
  • CMMB N/A
  • Revenue
  • OXLCO N/A
  • CMMB N/A
  • Revenue This Year
  • OXLCO N/A
  • CMMB N/A
  • Revenue Next Year
  • OXLCO N/A
  • CMMB N/A
  • P/E Ratio
  • OXLCO N/A
  • CMMB N/A
  • Revenue Growth
  • OXLCO N/A
  • CMMB N/A
  • 52 Week Low
  • OXLCO N/A
  • CMMB $0.55
  • 52 Week High
  • OXLCO N/A
  • CMMB $2.55
  • Technical
  • Relative Strength Index (RSI)
  • OXLCO 59.90
  • CMMB 56.98
  • Support Level
  • OXLCO $22.97
  • CMMB $2.02
  • Resistance Level
  • OXLCO $23.10
  • CMMB $2.15
  • Average True Range (ATR)
  • OXLCO 0.05
  • CMMB 0.12
  • MACD
  • OXLCO 0.01
  • CMMB -0.01
  • Stochastic Oscillator
  • OXLCO 88.09
  • CMMB 69.57

About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Share on Social Networks: